Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in mCRPC patients candidates to 223RaCl treatment. Radiol Oncol [Internet]. 2020 Mar. 25 [cited 2026 Nov. 1];54(1):40-7. Available from: https://www.radioloncol.com/index.php/ro/article/view/3297